Calado J - Search Results

1

Cysteine as a Multifaceted Player in Kidney, the Cysteine-Related Thiolome and Its Implications for Precision Medicine.

Correia MJ, Pimpão AB, Fernandes DGF, Morello J, Sequeira CO, Calado J, Antunes AMM, Almeida MS, Branco P, Monteiro EC, Vicente JB, Serpa J, Pereira SA. Correia MJ, et al. Among authors: calado j. Molecules. 2022 Feb 19;27(4):1416. doi: 10.3390/molecules27041416. Molecules. 2022. PMID: 35209204 Free PMC article. Review.

2

Effect of empagliflozin beyond glycemic control: Cardiovascular benefit in patients with type 2 diabetes and established cardiovascular disease.

Monteiro P, Aguiar C, Matos P, Silva-Nunes J, Birne R, Branco P, Calado J, Melo M, Polónia J. Monteiro P, et al. Among authors: calado j. Rev Port Cardiol (Engl Ed). 2019 Oct;38(10):721-735. doi: 10.1016/j.repc.2019.02.008. Epub 2019 Dec 28. Rev Port Cardiol (Engl Ed). 2019. PMID: 31892455 Free article. Review. English, Portuguese.

3

Zebrafish Model as a Screen to Prevent Cyst Inflation in Autosomal Dominant Polycystic Kidney Disease.

Oliveira I, Jacinto R, Pestana S, Nolasco F, Calado J, Lopes SS, Roxo-Rosa M. Oliveira I, et al. Among authors: calado j. Int J Mol Sci. 2021 Aug 20;22(16):9013. doi: 10.3390/ijms22169013. Int J Mol Sci. 2021. PMID: 34445719 Free PMC article.

4

The Na⁺ -coupled glucose transporter SGLT2 interacts with its accessory unit MAP17 in vitro and their expressions overlap in the renal proximal tubule.

Calado J, Santos AR, Aires I, Lebre F, Nolasco F, Rueff J, Ramalho J. Calado J, et al. FEBS Lett. 2018 Oct;592(19):3317-3326. doi: 10.1002/1873-3468.13233. Epub 2018 Sep 8. FEBS Lett. 2018. PMID: 30156268 Free article.

5

Dapagliflozin, an oral sodium glucose cotransporter type 2 inhibitor for the treatment of type 2 diabetes mellitus.

Calado J. Calado J. IDrugs. 2009 Dec;12(12):785-98. IDrugs. 2009. PMID: 19943222 Review.

6

Familial renal glucosuria and SGLT2: from a mendelian trait to a therapeutic target.

Santer R, Calado J. Santer R, et al. Among authors: calado j. Clin J Am Soc Nephrol. 2010 Jan;5(1):133-41. doi: 10.2215/CJN.04010609. Epub 2009 Nov 5. Clin J Am Soc Nephrol. 2010. PMID: 19965550 Review.

7

BI-10773, a sodium-glucose cotransporter 2 inhibitor for the potential oral treatment of type 2 diabetes mellitus.

Aires I, Calado J. Aires I, et al. Among authors: calado j. Curr Opin Investig Drugs. 2010 Oct;11(10):1182-90. Curr Opin Investig Drugs. 2010. PMID: 20872321 Review.

8

Novel compound heterozygous mutations in SLC5A2 are responsible for autosomal recessive renal glucosuria.

Calado J, Soto K, Clemente C, Correia P, Rueff J. Calado J, et al. Hum Genet. 2004 Feb;114(3):314-6. doi: 10.1007/s00439-003-1054-x. Epub 2003 Nov 12. Hum Genet. 2004. PMID: 14614622

9

Gene Symbol: SLC55A2. Disease: familial renal glucosuria.

Calado J, Soto K, Clemente C, Correia P, Rueff J. Calado J, et al. Hum Genet. 2004 Jul;115(2):170. Hum Genet. 2004. PMID: 15300967 No abstract available.

10

A novel heterozygous missense mutation in the UMOD gene responsible for Familial Juvenile Hyperuricemic Nephropathy.

Calado J, Gaspar A, Clemente C, Rueff J. Calado J, et al. BMC Med Genet. 2005 Jan 27;6:5. doi: 10.1186/1471-2350-6-5. BMC Med Genet. 2005. PMID: 15673476 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

50 results

Search Page